Retatrutide – Triple Receptor Agonist
Retatrutide is an exciting investigational peptide currently drawing attention in metabolic and endocrine research. Known as a triple agonist, it simultaneously activates GLP-1, GIP, and glucagon receptors, a unique profile that sets it apart from other incretin-based peptides. This multi-receptor activity has made Retatrutide an important subject of ongoing studies into energy regulation, weight management, and glucose metabolism.
Researchers are particularly interested in:
The synergy between GLP-1, GIP, and glucagon receptor pathways
How triple agonism may influence metabolic rate and energy balance
Potential long-term effects on insulin sensitivity and body composition
As a cutting-edge research peptide, Retatrutide represents the next generation of incretin-based compounds. Its novel structure and mechanism make it a valuable tool for laboratories exploring new horizons in metabolic health.
For laboratory research use only. Not for human consumption.
Retatrutide – Triple Receptor Agonist
LabPure Peptides accepts returns only for items damaged during shipping. Claims must be submitted within 3 business days of delivery with photos sent to LabPurePeptides@gmail.com. No other returns or exchanges are accepted. All products are sold for research use only and are not for human consumption.
Research Use Only Disclosure
Disclaimer: All products sold by LabPure Peptides are for laboratory research use only. Not for human consumption, medical, or veterinary use. Buyer assumes all responsibility for proper handling and lawful use.